Clinical Trial Update: Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE) [Phase 4]

View source ↗

Summary

Phase 4 trial in patients with atrial fibrillation and dialysis-dependent kidney failure comparing a vitamin K antagonist, a Factor Xa inhibitor, or no anticoag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Factor Xa inhibitor
• Vitamin K antagonist

Snippet

Sponsor: Hospital Sirio-Libanes | Conditions: Atrium; Fibrillation, Chronic Kidney Diseases | Phase 4 | Status: RECRUITING